Pilot trial shows EMST improves swallowing function in survivors of head and neck cancer, suggesting its feasibility and safety.
EMST is feasible, safe, and improves expiratory and swallowing function in aspirating HNC survivors, warranting randomized trials.
No takes yet. Share an insight, caveat, or question.
Manduchi et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: